CVE-2025-41232

CVE-2025-41232: Spring Security authorization bypass for method security annotations on private methods

Description

Spring Security Aspects may not correctly locate method security annotations on private methods. This can cause an authorization bypass. Your application may be affected by this if the following are true: * You are using @EnableMethodSecurity(mode=ASPECTJ) and spring-security-aspects, and * You have Spring Security method annotations on a private method In that case, the target method may be able to be invoked without proper authorization. You are not affected if: * You are not using @EnableMethodSecurity(mode=ASPECTJ) or spring-security-aspects, or * You have no Spring Security-annotated private methods

Category

9.1
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 0.05%
Affected: Spring Spring Security
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-41232?
CVE-2025-41232 has been scored as a critical severity vulnerability.
How to fix CVE-2025-41232?
To fix CVE-2025-41232, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-41232 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-41232 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-41232?
CVE-2025-41232 affects Spring Spring Security.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.